CompletedNCT00854919
Antipsychotic add-on therapy or exposure practice for OCD not helped by SSRIs
About this title
Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
Read the official source — NCT00854919Medication studyAges 20–50Japan
Understand this study
Who was this study for?
Listed age limits: 20 years to 50 years.
- Listed locations
- OsakaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Osaka City University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Japan
- Age range
- From 20 Years to 50 Years
- Official registry ID
- NCT00854919
- Official title
Show the full official title
An Long Term Trial on Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Osaka
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Osaka City University, a university.
Did this study involve medication?
Yes. The study involved medication, including atypical antipsychotic drug.
Who was this study for?
Listed age limits: 20 years to 50 years.
